What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size

Por Katherine M. Keyes, Caroline Rutherford, Ava Hamilton, Joshua A. Barocas, Kitty H. Gelberg, Peter P. Mueller, Daniel J. Feaster, Nabila El-Bassel, Magdalena Cerdá
Publicado em 2022-06-01

Readiness and barriers to adopt evidence-based practices for substance abuse treatment in Mexico

Por Viviana E. Horigian, Paula S. Espinal, Elizabeth Alonso, Rosa E. Verdeja, Rui Duan, Ingrid M. Usaga, Alejandro Pérez-López, Rodrigo Marín-Navarrete, Daniel J. Feaster
Publicado no Salud Mental (2016)

Intervención de incremento motivacional en centros ambulatorios para las adicciones: un ensayo aleatorizado multi-céntrico

Por Rodrigo Marín-Navarrete, Viviana E. Horigian, María Elena Medina-Mora, Rosa E. Verdeja, Elizabeth Alonso, Daniel J. Feaster, José Fernández-Mondragón, Carlos Berlanga, Ricardo Sánchez-Huesca, Carlos Lima-Rodríguez, Ana de la Fuente-Martín
Publicado no International Journal of Clinical and Health Psychology (2017)

M2HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID

Por Valérie Martel-Laferrière, Daniel J. Feaster, Lisa R. Metsch, Bruce R. Shackman, Christine Loignon, Bohdan Nosyk, Hansel Tookes, Czarina N. Behrends, Nelson Arruda, Oluleye Adigun, Marie-Eve Goyer, Michael A. Kolber, Jean-Francois Mary, Allan E. Rodriguez, Iveth G. Yanez, Yue Pan, Rania Khemiri, Lauren Gooden, Aïssata Sako, Julie Bruneau
Publicado em 2022-04-01